Haleon Plc (HLN)
9.665
-0.20
(-1.98%)
USD |
NYSE |
Sep 04, 10:30
Haleon Market Cap : 42.40B for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 03, 2026 | 43.26B |
| September 02, 2026 | 43.47B |
| September 01, 2026 | 44.18B |
| August 31, 2026 | 44.00B |
| August 28, 2026 | 44.35B |
| August 27, 2026 | 44.04B |
| August 26, 2026 | 44.62B |
| August 25, 2026 | 44.66B |
| August 24, 2026 | 44.57B |
| August 21, 2026 | 43.87B |
| August 20, 2026 | 43.30B |
| August 19, 2026 | 43.30B |
| August 18, 2026 | 42.64B |
| August 17, 2026 | 42.03B |
| August 14, 2026 | 42.55B |
| August 13, 2026 | 42.99B |
| August 12, 2026 | 42.99B |
| August 11, 2026 | 43.56B |
| August 10, 2026 | 43.56B |
| August 07, 2026 | 44.00B |
| August 06, 2026 | 44.00B |
| August 05, 2026 | 43.65B |
| August 04, 2026 | 42.90B |
| August 03, 2026 | 42.99B |
| July 31, 2026 | 43.30B |
| Date | Value |
|---|---|
| July 30, 2026 | 44.35B |
| July 29, 2026 | 45.10B |
| July 28, 2026 | 45.05B |
| July 27, 2026 | 43.61B |
| July 24, 2026 | 42.90B |
| July 23, 2026 | 42.60B |
| July 22, 2026 | 43.21B |
| July 21, 2026 | 43.52B |
| July 20, 2026 | 44.04B |
| July 17, 2026 | 44.31B |
| July 16, 2026 | 44.35B |
| July 15, 2026 | 42.77B |
| July 14, 2026 | 42.55B |
| July 13, 2026 | 43.26B |
| July 10, 2026 | 42.82B |
| July 09, 2026 | 42.60B |
| July 08, 2026 | 42.77B |
| July 07, 2026 | 43.17B |
| July 06, 2026 | 42.64B |
| July 02, 2026 | 43.08B |
| July 01, 2026 | 41.24B |
| June 30, 2026 | 40.93B |
| June 29, 2026 | 41.54B |
| June 26, 2026 | 41.14B |
| June 25, 2026 | 41.28B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 503.40B |
| GSK Plc | 100.95B |
| Hikma Pharmaceuticals Plc | 4.572B |
| Allergy Therapeutics Plc | 921.22M |
| Shield Therapeutics Plc | 91.58M |
Market Cap Related Metrics
| PE Ratio | 19.87 |
| PS Ratio | 2.891 |
| PEG Ratio | 0.3132 |
| Price to Free Cash Flow | 16.45 |
| Price | 9.665 |
| Earnings Yield | 5.03% |
| PEGY Ratio | 0.3037 |
| Operating PE Ratio | 12.41 |
| Normalized PE Ratio | 18.06 |